Caroline Imbert

825 total citations
19 papers, 468 citations indexed

About

Caroline Imbert is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Caroline Imbert has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Caroline Imbert's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (4 papers). Caroline Imbert is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (4 papers). Caroline Imbert collaborates with scholars based in France, Belgium and United States. Caroline Imbert's co-authors include Bruno Ségui, Céline Colacios, Nathalie Andrieu‐Abadie, Thierry Levade, Julia Gilhodes, Thomas Filleron, Nicolás Meyer, Elie Marcheteau, Florie Bertrand and Philippe Rochaix and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Caroline Imbert

19 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Imbert France	7	278	268	126	39	31	19	468
Naoshi Kawamura Japan	10	233 0.8×	204 0.8×	156 1.2×	57 1.5×	46 1.5×	12	456
Hoainam Nguyen-Jackson United States	7	188 0.7×	360 1.3×	104 0.8×	55 1.4×	26 0.8×	8	530
Julie Duong United States	4	259 0.9×	433 1.6×	188 1.5×	51 1.3×	26 0.8×	4	626
Melissa Sandahl United States	8	205 0.7×	196 0.7×	207 1.6×	29 0.7×	29 0.9×	8	467
Kentaro Sumida Japan	9	295 1.1×	458 1.7×	100 0.8×	39 1.0×	19 0.6×	17	602
Eliran Ish‐Shalom Israel	7	323 1.2×	487 1.8×	140 1.1×	23 0.6×	29 0.9×	9	643
Yair Klieger Israel	7	172 0.6×	251 0.9×	104 0.8×	21 0.5×	22 0.7×	8	370
Junya Ohtake Japan	10	296 1.1×	276 1.0×	192 1.5×	68 1.7×	54 1.7×	18	524
Ioannis Tassiulas United States	9	149 0.5×	409 1.5×	113 0.9×	22 0.6×	27 0.9×	17	564
Asuka Kobayashi Japan	9	172 0.6×	139 0.5×	125 1.0×	54 1.4×	38 1.2×	15	359

Countries citing papers authored by Caroline Imbert

Since Specialization

Citations

This map shows the geographic impact of Caroline Imbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Imbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Imbert more than expected).

Fields of papers citing papers by Caroline Imbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Imbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Imbert. The network helps show where Caroline Imbert may publish in the future.

Co-authorship network of co-authors of Caroline Imbert

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Imbert. A scholar is included among the top collaborators of Caroline Imbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Imbert. Caroline Imbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Imbert, Caroline, Nicolas Boucherit, Laurent Gorvel, et al.. (2024). Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis. Cancer Immunology Research. 12(12). 1677–1690. 3 indexed citations

Wieduwild, Élisabeth, Caroline Imbert, Aude De Gassart, et al.. (2023). Evaluation of ICT01, a γ9δ2 T Cell-Activating Monoclonal Antibody, Combined with Venetoclax and Azacitidine in 1L AML (EVICTION Study). Blood. 142(Supplement 1). 1552–1552. 2 indexed citations

Wieduwild, Élisabeth, Sarah Bourass, Caroline Imbert, et al.. (2022). 354 Pulling the lever on all fronts: ICT01, a g9d2 T cell-activating monoclonal antibody, in combination with Venetoclax and 5-Azacytidine as a novel combination therapy for AML. Regular and Young Investigator Award Abstracts. A373–A373. 1 indexed citations

Marcheteau, Elie, Thomas Farge, Michaël Pérès, et al.. (2021). Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer. Cancers. 13(16). 4059–4059. 11 indexed citations

Cano, Carla E., Christine L. Pasero, Aude De Gassart, et al.. (2021). BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells. Cell Reports. 36(2). 109359–109359. 57 indexed citations

Imbert, Caroline, Aude De Gassart, Florence Orlanducci, et al.. (2021). Targeting BTN2A1 By a Unique Activating Mab Improves Vγ9Vδ2 T Cell Cytotoxicity Against Primary Acute Lymphoblastic Blasts. Blood. 138(Supplement 1). 2302–2302. 2 indexed citations

Imbert, Caroline & Daniel Olive. (2020). γδ T Cells in Tumor Microenvironment. Advances in experimental medicine and biology. 1273. 91–104. 17 indexed citations

Cano, Carla E., Aude De Gassart, Christine L. Pasero, et al.. (2020). 211 Targeting BTN2A1 modulates anti-tumor activity of Vg9Vd2 T cells. SHILAP Revista de lepidopterología. A126.2–A127. 2 indexed citations

Ghigo, Clément, et al.. (2020). 3 Butyrophilin-3a is expressed in multiple solid tumors: translational research supporting the EVICTION study with ICT01, an anti-BTN3A mAb activating Vg9Vd2 T-Cells. SHILAP Revista de lepidopterología. A2.1–A2. 4 indexed citations

10.

Garandeau, David, J. C. Leclerc, Caroline Imbert, et al.. (2018). Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Molecular Cancer Therapeutics. 18(2). 289–300. 26 indexed citations

11.

Bertrand, Florie, Anne Montfort, Elie Marcheteau, et al.. (2017). TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma. Nature Communications. 8(1). 2256–2256. 281 indexed citations

12.

Imbert, Caroline, Virginie Garcia, Florian Rambow, et al.. (2016). Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma. Oncotarget. 7(44). 71873–71886. 33 indexed citations

13.

Imbert, Caroline, et al.. (2011). Pour une catégorie de “satellite” de Trajectoire dans une approche fonctionnelle-typologique. Faits de langues. 38(2). 99–116. 5 indexed citations

14.

Campos, Lydia, Caroline Imbert, O Gentilhomme, et al.. (1984). Serum beta 2 microglobulin in adult myeloid acute leukemias. Annals of Hematology. 48(4). 221–226. 6 indexed citations

15.

Imbert, Caroline, et al.. (1983). Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.. British Journal of Clinical Pharmacology. 15(6). 735–741. 7 indexed citations

16.

Guyotat, D, D Fière, P Adeleine, et al.. (1982). [Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].. PubMed. 11(49). 3637–9. 3 indexed citations

17.

Sébahoun, G, Caroline Imbert, Danielle Sainty, & Y Carcassonne. (1980). [Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)].. PubMed. 131(2). 75–7. 2 indexed citations

18.

Sébahoun, G, Caroline Imbert, & Y Carcassonne. (1980). [Mediterranean visceral leishmaniasis in the adult: 13 cases].. PubMed. 9(8). 531–2. 5 indexed citations

19.

Imbert, Caroline, et al.. (1978). [Solitary secreting plasmocytoma in a femoral localization in a young man (author's transl)].. PubMed. 65(2). 111–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact